NO179094C - Fremgangsmåte for fremstilling av et farmasöytisk preparat for påföring på slimhinnen - Google Patents

Fremgangsmåte for fremstilling av et farmasöytisk preparat for påföring på slimhinnen

Info

Publication number
NO179094C
NO179094C NO883468A NO883468A NO179094C NO 179094 C NO179094 C NO 179094C NO 883468 A NO883468 A NO 883468A NO 883468 A NO883468 A NO 883468A NO 179094 C NO179094 C NO 179094C
Authority
NO
Norway
Prior art keywords
denotes
amino acid
mucosa
preparing
application
Prior art date
Application number
NO883468A
Other languages
English (en)
Other versions
NO883468L (no
NO883468D0 (no
NO179094B (no
Inventor
Jurgen Kurt Sandow
Rainer Schmiedel
Klaus Wirth
Hans Peter Merkle
Susanne Raechs
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO883468D0 publication Critical patent/NO883468D0/no
Publication of NO883468L publication Critical patent/NO883468L/no
Publication of NO179094B publication Critical patent/NO179094B/no
Publication of NO179094C publication Critical patent/NO179094C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Materials For Medical Uses (AREA)
NO883468A 1987-08-07 1988-08-04 Fremgangsmåte for fremstilling av et farmasöytisk preparat for påföring på slimhinnen NO179094C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873726324 DE3726324A1 (de) 1987-08-07 1987-08-07 Cyclopeptide als resorptionsfoerderer bei applikation auf die schleimhaeute

Publications (4)

Publication Number Publication Date
NO883468D0 NO883468D0 (no) 1988-08-04
NO883468L NO883468L (no) 1989-02-08
NO179094B NO179094B (no) 1996-04-29
NO179094C true NO179094C (no) 1996-08-07

Family

ID=6333298

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883468A NO179094C (no) 1987-08-07 1988-08-04 Fremgangsmåte for fremstilling av et farmasöytisk preparat for påföring på slimhinnen

Country Status (19)

Country Link
US (1) US5091365A (no)
EP (1) EP0302466B1 (no)
JP (1) JP2764930B2 (no)
KR (1) KR970004039B1 (no)
AT (1) ATE69556T1 (no)
AU (1) AU608878B2 (no)
CA (1) CA1331131C (no)
DE (2) DE3726324A1 (no)
DK (1) DK168273B1 (no)
ES (1) ES2038725T3 (no)
FI (1) FI883643A (no)
GR (1) GR3003733T3 (no)
HU (1) HU199301B (no)
IE (1) IE60871B1 (no)
IL (1) IL87362A0 (no)
NO (1) NO179094C (no)
NZ (1) NZ225715A (no)
PT (1) PT88192B (no)
ZA (1) ZA885724B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW274552B (no) * 1992-05-26 1996-04-21 Hoechst Ag
PT710243E (pt) * 1993-06-29 2000-11-30 Ferring Bv Sintese melhorada de peptidos ciclicos.
US5767068A (en) * 1997-02-13 1998-06-16 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
IT1294191B1 (it) * 1997-09-05 1999-03-22 Alfa Wassermann Spa Composizioni farmaceutiche contenenti calcitonina in un dosatore spray per somministrazione intranasale.
KR100611559B1 (ko) * 1998-05-08 2007-04-25 동아제약주식회사 칼시토닌을 함유한 비강투여용 약제학적 조성물
SE514606C2 (sv) * 1998-08-26 2001-03-19 Laekartjaenster I Vaestsverige Läkemedel innehållande GnRH-analoger för behandling av schizofreni
DE10014007A1 (de) * 2000-03-22 2001-10-11 Strathmann Ag & Co Neue Darreichungsformen für DSIP
US20020141970A1 (en) * 2001-03-05 2002-10-03 Pettit Dean K. Stable aqueous solutions of granulocyte macrophage colony-stimulating factor
WO2004084859A2 (en) * 2003-03-21 2004-10-07 Nastech Pharmaceutical Company Inc. Nasal calcitonin formulations containing chlorobutanol
PT3445778T (pt) 2016-04-19 2020-10-15 Griffon Pharmaceuticals Int Sa C/O Biopole Sa Péptidos bioativos peguilados e suas utilizações
EP3973990A4 (en) * 2019-03-25 2023-07-19 University of Tsukuba PROMOTOR FOR PERMEATION INTO A CELL LAYER, COMPOSITION TO ENABLE DRUG ABSORPTION AND PHARMACEUTICAL COMPOSITION

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0037943B1 (en) * 1980-03-31 1985-08-14 Teijin Limited Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom
US4900730A (en) * 1981-01-14 1990-02-13 Toyo Jozo Co., Ltd. Preparation which promotes the absorption of peptides
JPS58140026A (ja) * 1982-01-14 1983-08-19 Toyo Jozo Co Ltd 吸収性良好な製剤
FR2509175B1 (fr) * 1981-03-06 1987-01-16 Toyo Jozo Kk Preparation therapeutique ayant d'excellentes proprietes d'absorption
US4568665A (en) 1982-06-25 1986-02-04 Mitchell David C Protein compounds
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
CA1249968A (en) * 1984-04-05 1989-02-14 Kazuo Kigasawa Ointment base
US4537772A (en) * 1984-05-02 1985-08-27 Merck & Co., Inc. Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines
JPS6160620A (ja) * 1984-09-03 1986-03-28 Teijin Ltd ピログルタミン酸エステル類を含有する医薬品組成物
DE3532074A1 (de) * 1985-09-09 1987-03-12 Berlin Chemie Veb Resorptionsvermittler fuer biologisch aktive peptide

Also Published As

Publication number Publication date
US5091365A (en) 1992-02-25
NO883468L (no) 1989-02-08
DK440888A (da) 1989-02-08
FI883643A (fi) 1989-02-08
DK168273B1 (da) 1994-03-07
DK440888D0 (da) 1988-08-05
EP0302466B1 (de) 1991-11-21
NO883468D0 (no) 1988-08-04
NO179094B (no) 1996-04-29
ATE69556T1 (de) 1991-12-15
PT88192A (pt) 1989-06-30
DE3866307D1 (de) 1992-01-02
EP0302466A1 (de) 1989-02-08
IE882408L (en) 1989-02-07
AU2043388A (en) 1989-04-20
KR890003409A (ko) 1989-04-14
PT88192B (pt) 1995-03-01
GR3003733T3 (no) 1993-03-16
AU608878B2 (en) 1991-04-18
ZA885724B (en) 1989-04-26
HU199301B (en) 1990-02-28
JPS6466128A (en) 1989-03-13
DE3726324A1 (de) 1989-02-16
JP2764930B2 (ja) 1998-06-11
NZ225715A (en) 1991-02-26
CA1331131C (en) 1994-08-02
HUT47599A (en) 1989-03-28
KR970004039B1 (ko) 1997-03-24
IL87362A0 (en) 1989-01-31
IE60871B1 (en) 1994-08-24
ES2038725T3 (es) 1993-08-01
FI883643A0 (fi) 1988-08-04

Similar Documents

Publication Publication Date Title
FI98460B (fi) Menetelmä terapeuttisesti käyttökelpoisen 4H-1-bentsopyran-4-onijohdoksen tai sen suolan valmistamiseksi ja menetelmässä käyttökelpoinen välituote
NZ225344A (en) 3-demethylmevalonic acid derivatives and lactones and pharmaceutical compositions; intermediates for the preparation thereof
EE200200245A (et) Farmatseutiline kompositsioon, mis sisaldab tolterodiini ja selle kasutamine
EE04800B1 (et) Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks
SE8300736D0 (sv) Novel pharmacologically active compounds
ES520226A0 (es) Procedimiento para la preparacion de derivados de cefem.
ES2084579T3 (es) Uso de buspirona en la preparacion de una composicion farmaceutica para el tratamiento del abuso del alcohol.
NO179094C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat for påföring på slimhinnen
NO903911D0 (no) Fremgangsmaate for fremstilling av 4-hydroksytetrahydropyran-2-on og de tilsvarende dihydroksykarboksylsyrederivater, salter og estere, deres anvendelse som legemidler, farmasoeytiske preparater og forprodukter.
MX9205461A (es) Solucion acuosa estable de esparfloxacina y metodopara su preparacion
ATE110723T1 (de) Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung.
DK408083D0 (da) Isoquinilinderivater, deres fremstilling og anvendelse
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
FI893677A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 6-fluori-3,5-dihydroksikarboksyylihappojen ja niiden johdannaisten valmistamiseksi
SE8402199L (sv) Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist
ATE270T1 (de) Neue n1-benzoyl-n2-phenyl-1,3-diaminopropan-2-ole und ihre salze; verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel.
SE8603517D0 (sv) Heterocyclic compounds and their preparation and pharmaceutical formulation
DE59002790D1 (de) Verfahren zur Herstellung einer Galenischen Zubereitung mit optimaler Bioverfügbarkeit des Wirkstoffs 2-Hydroxy-5-methyllaurophenonoxime (HMLO).
IT8321031A0 (it) Loro derivati, aventi attivita'sali di calcio di amminoacidi o di terapeutica, procedimento per laloro preparazione e composizioni farmaceutiche che li contengono.
SE0000782D0 (sv) Pharmaceutical formulation and its use

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN FEBRUARY 2002